Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−5 JPY
338.27 M JPY
12.31 B JPY
9.24 M
About LINICAL CO LTD
Sector
Headquarters
Osaka
Website
Founded
2005
ISIN
JP3974530002
FIGI
BBG000J4YN11
Linical Co., Ltd. engages in pharmaceutical contract research projects providing consulting, monitoring, and quality control services to pharmaceutical companies. It operates through the Contract Research Organization (CRO) and Pharmaceutical business segments. The CRO business segment provides outsourced pharmaceutical development services. The Pharmaceutical business segment handles marketing support on products of the pharmaceutical companies. The company was founded by Kazuhiro Hatano on June 7, 2005 and is headquartered in Osaka, Japan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 2183 is 356 JPY — it has decreased by −1.11% in the past 24 hours. Watch LINICAL CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange LINICAL CO LTD stocks are traded under the ticker 2183.
2183 stock has fallen by −0.56% compared to the previous week, the month change is a 7.23% rise, over the last year LINICAL CO LTD has showed a −31.93% decrease.
2183 reached its all-time high on Jul 18, 2018 with the price of 2,584 JPY, and its all-time low was 111 JPY and was reached on Sep 26, 2011. View more price dynamics on 2183 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
2183 stock is 2.56% volatile and has beta coefficient of 0.31. Track LINICAL CO LTD stock price on the chart and check out the list of the most volatile stocks — is LINICAL CO LTD there?
Today LINICAL CO LTD has the market capitalization of 8.13 B, it has increased by 2.03% over the last week.
Yes, you can track LINICAL CO LTD financials in yearly and quarterly reports right on TradingView.
LINICAL CO LTD is going to release the next earnings report on Feb 14, 2025. Keep track of upcoming events with our Earnings Calendar.
LINICAL CO LTD revenue for the last quarter amounts to 2.50 B JPY, despite the estimated figure of 3.06 B JPY. In the next quarter, revenue is expected to reach 3.25 B JPY.
2183 net income for the last quarter is −198.22 M JPY, while the quarter before that showed −82.30 M JPY of net income which accounts for −140.87% change. Track more LINICAL CO LTD financial stats to get the full picture.
LINICAL CO LTD dividend yield was 3.81% in 2023, and payout ratio reached 100.16%. The year before the numbers were 2.01% and 31.48% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jan 15, 2025, the company has 662.00 employees. See our rating of the largest employees — is LINICAL CO LTD on this list?
Like other stocks, 2183 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LINICAL CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LINICAL CO LTD technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LINICAL CO LTD stock shows the sell signal. See more of LINICAL CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.